HOXC8 and non-small cell lung carcinoma: Moreover, the enhanced apoptosis induced by cisplatin in combination with HOXC8 knockdown suggested that the combination of cisplatin with other therapies that modulated HOXC8 could be exploited as a plausible strategy to enhance therapeutic efficacy for NSCLC.